Skip to main content
. 2021 Nov 24;12:760181. doi: 10.3389/fpsyt.2021.760181

Table 2.

Key antipsychotic targets + associated drug benefit and AE impact examples.

Target Clinical effects associated with antagonism or partial agonism
Desired Adverse effects (AE)
D2(*) Antipsychotic (positive symptoms) EPS, prolactin ↑, sexual dysfunction and cognition ↓
D3* Antipsychotic (negative symptoms)
5-HT1A* Anxiolytic, antidepressant, anti-EPS(?)
5-HT2A Anti-EPS and –akathisia
5-HT2C Appetite/weight ↑ and metabolic effects
H1 Sedation Sedation, cognition ↓, appetite/ weight ↑
Alpha1 Hypotension, sexual dysfunction
Muscarinic Anti-EPS Dry mouth, constipation, blurry vision, cognition ↓
*

Partial agonism

(*)

Antagonism (Desired and Adverse Effects) or partial agonism (only Desired).